HKMPY
Price
$44.97
Change
+$1.92 (+4.46%)
Updated
Sep 26 closing price
Capitalization
4.85B
INDV
Price
$23.92
Change
+$1.11 (+4.87%)
Updated
Sep 26 closing price
Capitalization
2.98B
24 days until earnings call
Interact to see
Advertisement

HKMPY vs INDV

Header iconHKMPY vs INDV Comparison
Open Charts HKMPY vs INDVBanner chart's image
Hikma Pharmaceuticals
Price$44.97
Change+$1.92 (+4.46%)
Volume$3.93K
Capitalization4.85B
Indivior
Price$23.92
Change+$1.11 (+4.87%)
Volume$2.81M
Capitalization2.98B
HKMPY vs INDV Comparison Chart in %
Loading...
HKMPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HKMPY vs. INDV commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HKMPY is a Hold and INDV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (HKMPY: $44.97 vs. INDV: $23.92)
Brand notoriety: HKMPY and INDV are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HKMPY: 153% vs. INDV: 85%
Market capitalization -- HKMPY: $4.85B vs. INDV: $2.98B
HKMPY [@Pharmaceuticals: Generic] is valued at $4.85B. INDV’s [@Pharmaceuticals: Generic] market capitalization is $2.98B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HKMPY’s FA Score shows that 1 FA rating(s) are green whileINDV’s FA Score has 0 green FA rating(s).

  • HKMPY’s FA Score: 1 green, 4 red.
  • INDV’s FA Score: 0 green, 5 red.
According to our system of comparison, INDV is a better buy in the long-term than HKMPY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HKMPY’s TA Score shows that 4 TA indicator(s) are bullish while INDV’s TA Score has 5 bullish TA indicator(s).

  • HKMPY’s TA Score: 4 bullish, 3 bearish.
  • INDV’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, INDV is a better buy in the short-term than HKMPY.

Price Growth

HKMPY (@Pharmaceuticals: Generic) experienced а +1.38% price change this week, while INDV (@Pharmaceuticals: Generic) price change was +6.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

INDV is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HKMPY($4.86B) has a higher market cap than INDV($2.98B). INDV has higher P/E ratio than HKMPY: INDV (29.53) vs HKMPY (13.46). INDV YTD gains are higher at: 92.438 vs. HKMPY (-7.067). HKMPY has higher annual earnings (EBITDA): 734M vs. INDV (261M). INDV has more cash in the bank: 510M vs. HKMPY (236M). INDV has less debt than HKMPY: INDV (366M) vs HKMPY (1.56B). HKMPY has higher revenues than INDV: HKMPY (3.22B) vs INDV (1.17B).
HKMPYINDVHKMPY / INDV
Capitalization4.86B2.98B163%
EBITDA734M261M281%
Gain YTD-7.06792.438-8%
P/E Ratio13.4629.5346%
Revenue3.22B1.17B274%
Total Cash236M510M46%
Total Debt1.56B366M426%
FUNDAMENTALS RATINGS
HKMPY vs INDV: Fundamental Ratings
HKMPY
INDV
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
94
Overvalued
PROFIT vs RISK RATING
1..100
10049
SMR RATING
1..100
7977
PRICE GROWTH RATING
1..100
8336
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HKMPY's Valuation (9) in the null industry is significantly better than the same rating for INDV (94). This means that HKMPY’s stock grew significantly faster than INDV’s over the last 12 months.

INDV's Profit vs Risk Rating (49) in the null industry is somewhat better than the same rating for HKMPY (100). This means that INDV’s stock grew somewhat faster than HKMPY’s over the last 12 months.

INDV's SMR Rating (77) in the null industry is in the same range as HKMPY (79). This means that INDV’s stock grew similarly to HKMPY’s over the last 12 months.

INDV's Price Growth Rating (36) in the null industry is somewhat better than the same rating for HKMPY (83). This means that INDV’s stock grew somewhat faster than HKMPY’s over the last 12 months.

HKMPY's P/E Growth Rating (95) in the null industry is in the same range as INDV (100). This means that HKMPY’s stock grew similarly to INDV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HKMPYINDV
RSI
ODDS (%)
Bullish Trend 4 days ago
36%
Bearish Trend 4 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
40%
Bullish Trend 4 days ago
73%
Momentum
ODDS (%)
Bearish Trend 4 days ago
55%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bullish Trend 4 days ago
51%
Bearish Trend 5 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
45%
Bullish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 4 days ago
70%
Advances
ODDS (%)
N/A
Bullish Trend 25 days ago
73%
Declines
ODDS (%)
Bearish Trend 5 days ago
64%
Bearish Trend 5 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
45%
Bullish Trend 4 days ago
67%
Aroon
ODDS (%)
Bearish Trend 4 days ago
73%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
HKMPY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRIEX28.120.24
+0.86%
Nuveen International Eq Idx Retire
GSAHX16.570.11
+0.67%
Goldman Sachs Small Cap Growth Investor
OCRDX20.910.10
+0.48%
Invesco Rising Dividends C
MTODX22.610.08
+0.36%
NYLI Income Builder Class R6
ETIEX14.44-0.02
-0.14%
Eventide Exponential Technologies I

HKMPY and

Correlation & Price change

A.I.dvisor tells us that HKMPY and HYPMY have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKMPY and HYPMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPY
1D Price
Change %
HKMPY100%
+4.46%
HYPMY - HKMPY
14%
Poorly correlated
+5.00%
JUSHF - HKMPY
5%
Poorly correlated
+0.05%
HLTRF - HKMPY
4%
Poorly correlated
-0.78%
INDV - HKMPY
3%
Poorly correlated
+4.87%
GTBIF - HKMPY
2%
Poorly correlated
-2.02%
More

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and ALKS have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and ALKS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
+4.87%
ALKS - INDV
25%
Poorly correlated
+2.80%
DRRX - INDV
25%
Poorly correlated
N/A
HROW - INDV
23%
Poorly correlated
+2.06%
AMRX - INDV
23%
Poorly correlated
+1.56%
VTRS - INDV
22%
Poorly correlated
+0.32%
More